Dharam V. Ablashi

10.3k total citations · 1 hit paper
142 papers, 6.4k citations indexed

About

Dharam V. Ablashi is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Dharam V. Ablashi has authored 142 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Epidemiology, 86 papers in Oncology and 33 papers in Infectious Diseases. Recurrent topics in Dharam V. Ablashi's work include Cytomegalovirus and herpesvirus research (93 papers), Viral-associated cancers and disorders (82 papers) and Herpesvirus Infections and Treatments (65 papers). Dharam V. Ablashi is often cited by papers focused on Cytomegalovirus and herpesvirus research (93 papers), Viral-associated cancers and disorders (82 papers) and Herpesvirus Infections and Treatments (65 papers). Dharam V. Ablashi collaborates with scholars based in United States, Germany and Canada. Dharam V. Ablashi's co-authors include S. Zaki Salahuddin, Flossie Wong‐Staal, Steven F. Josephs, Robert C. Gallo, Phillip D. Markham, Mark H. Kaplan, Peter Biberfeld, Richard L. Gallo, Louise G. Chatlynne and James E. Whitman and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Dharam V. Ablashi

140 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders

1986 1.1k citations S. Zaki Salahuddin, Dharam V. Ablashi et al. profile →

Peers

Countries citing papers authored by Dharam V. Ablashi

Since Specialization

Citations

This map shows the geographic impact of Dharam V. Ablashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharam V. Ablashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharam V. Ablashi more than expected).

Fields of papers citing papers by Dharam V. Ablashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharam V. Ablashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharam V. Ablashi. The network helps show where Dharam V. Ablashi may publish in the future.

Co-authorship network of co-authors of Dharam V. Ablashi

This figure shows the co-authorship network connecting the top 25 collaborators of Dharam V. Ablashi. A scholar is included among the top collaborators of Dharam V. Ablashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharam V. Ablashi. Dharam V. Ablashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures 2023 ·Veterinary Medicine and Science ·(unknown), Máté Hídvégi, (unknown), K. Nagy, (unknown), Dharam V. Ablashi, (unknown), (unknown)	2
2	Transfer Factor as an Option for Managing the COVID-19 Pandemic 2020 ·Folia Biologica ·D. Viza, (unknown), Concetta Vinci, Giovanni Brandi, Dharam V. Ablashi	3
3	Copy Number Heterogeneity, Large Origin Tandem Repeats, and Interspecies Recombination in Human Herpesvirus 6A (HHV-6A) and HHV-6B Reference Strains 2018 ·Journal of Virology ·Alexander L. Greninger, Pavitra Roychoudhury, Negar Makhsous, Derek Hanson, (unknown), G. R. F. Krueger, Hong Xie, Meei‐Li Huang, Lindsay Saunders, Dharam V. Ablashi, David M. Koelle, Linda Cook, Keith R. Jerome	18
4	Anti-herpesviral effects of a novel broad range anti-microbial quaternary ammonium silane, K21 2016 ·Antiviral Research ·Nitish Gulve, (unknown), (unknown), G. R. F. Krueger, Dharam V. Ablashi, Bhupesh K. Prusty	16
5	The Antimicrobial Compound, K21, Inhibits Replication of Enveloped and Non-Enveloped DNA and RNA Viruses 2015 ·Journal of Antivirals & Antiretrovirals ·Dharam V. Ablashi	1
6	Mapping the telomere integrated genome of human herpesvirus 6A and 6B 2013 ·Virology ·Jesse H. Arbuckle, Shara N. Pantry, Maria M. Medveczky, (unknown), Kristin S. Loomis, Dharam V. Ablashi, Peter G. Medveczky	50
7	Quantitative HHV-6B antigenemia test for the monitoring of transplant patients 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·Raisa Loginov, (unknown), K. Höckerstedt, Dharam V. Ablashi, (unknown)	9
8	Review part 2: Human herpesvirus‐6 in central nervous system diseases 2010 ·Journal of Medical Virology ·Karen Yao, John R. Crawford, Anthony L. Komaroff, Dharam V. Ablashi, Steven Jacobson	71
9	HHV-6A infection induces expression of HERV-K18-encoded superantigen 2009 ·Journal of Clinical Virology ·Albert Tai, János Luka, Dharam V. Ablashi, Brigitte T. Huber	62
10	Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors 2003 ·Transfusion ·Philip E. Pellett, Deborah Wright, Eric A. Engels, Dharam V. Ablashi, Sheila C. Dollard, Bagher Forghani, Sharon A. Glynn, James J. Goedert, Frank J. Jenkins, (unknown), Frank Neipel, Deborah Todd, Denise Whitby, George J. Nemo, Michael P. Busch	110
11	Human herpesvirus type 8 in salivary gland tumors 2000 ·Journal of Clinical Virology ·Jens Peter Klußmann, Andreas Müller, Mathias Wagner, Orlando Guntinas‐Lichius, Markus Jungehuelsing, Theo P. Sloots, Dharam V. Ablashi, (unknown)	22
12	Human Herpesvirus 8 Cellular Immune Responses in Homosexual Men 1999 ·The Journal of Infectious Diseases ·Howard D. Strickler, James J. Goedert, Florian Bethke, Charles M. Trubey, Thomas R. OʼBrien, Joel M. Palefsky, James E. Whitman, Dharam V. Ablashi, Steven L. Zeichner, Gene M. Shearer	26
13	HHV-6 Infection in HIV-Infected Asymptomatic and AIDS Patients 1998 ·Intervirology ·Dharam V. Ablashi, (unknown), Mark H. Kaplan, James E. Whitman, Gary R. Pearson	22
14	Morphological and ultrastructural changes induced in corneal epithelial cells by HIV-1 and HHV-6 in vitro 1996 ·Current Eye Research ·Hamida Qavi, Bisong Xu, (unknown), Paolo Lusso, Gary R. Pearson, Dharam V. Ablashi	9
15	Summary: Viral Studies of Chronic Fatigue Syndrome 1994 ·Clinical Infectious Diseases ·Dharam V. Ablashi	30
16	RNA Drug Therapy Acting via the 2–5A Synthetase/RNase L Pathway 1993 ·Annals of the New York Academy of Sciences ·Robert J. Suhadolnik, Nancy L. Reichenbach, (unknown), Dharam V. Ablashi, David R. Strayer, (unknown)	1
17	Human herpes virus-6 (HHV-6) in diseases 1993 ·Clinical and Diagnostic Virology ·Syed Zaki Salahuddin, (unknown), G. R. F. Krueger, Steven F. Josephs, Sudhir Gupta, Dharam V. Ablashi	9
18	Antibody reactivity with two strains of human herpesvirus‐6 in Malaysians 1991 ·Journal of Medical Virology ·M Yadav, (unknown), Dharam V. Ablashi	7
19	Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 1989 ·Nature ·Paolo Lusso, Barbara Ensoli, Phillip D. Markham, Dharam V. Ablashi, S. Zaki Salahuddin, Erwin Tschachler, Flossie Wong‐Staal, Robert C. Gallo	245
20	Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6) 1988 ·International Journal of Cancer ·Dharam V. Ablashi, Paolo Lusso, Chia‐Ling Hung, S. Zaki Salahuddin, Steven F. Josephs, T Llana, Bernhard Kramarsky, Peter Biberfeld, Phillip D. Markham, Robert C. Gallo	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact